Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Recognizing the Support of the National Institutes of Health and the HIV Vaccine Trials Network in Advancing GeoVax’s HIV Vaccine Development Efforts ATLANTA, GA, May 16, 2019 (GLOBE NEWSWIRE) --...
-
ATLANTA, GA, May 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVXD), a biotechnology company developing human vaccines, announced that it will deliver a presentation...
-
ATLANTA, May 14, 2019 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVXD), a biotechnology company developing human vaccines, today announced its financial results for the three months ended March...
-
1:500 Reverse Split Effective May 2, 2019;Ticker Symbol Changed to GOVXD for 20 Days ATLANTA, GA , May 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX) today...
-
1:500 Reverse Split Effective May 2, 2019;Ticker Symbol Changed to GOVXD for 20 Days ATLANTA, GA, May 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX) today...
-
Bringing Attention to Malaria Vaccine Development Efforts ATLANTA, GA, April 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX) today is observing World Malaria Day,...
-
ATLANTA, March 27, 2019 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced its financial results for the year ended December 31,...
-
GeoVax Ebola Vaccine Provides Potential for 100% Protection from Single-Dose ATLANTA, GA, March 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology...
-
Selection in Two Award Categories follows GeoVax receiving the 2018 Best Biotech Award ATLANTA, GA, March 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a...
-
ATLANTA, GA, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines and immunotherapies using its novel viral vector...